Saarland University

Running trials

• Recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

  NCT07115953· Medtronic Vascular· Source

• Recruiting

  Digital Solutions for bEtter cAre

  NCT07416513· European Institute of Oncology· Source

• Recruiting

  Sex diffErences in prehoSpitAl Stroke MEdicine

  NCT06865950· Universität des Saarlandes· Source

• Recruiting

  SPYRAL GEMINI Pilot Study

  NCT06907147· Medtronic Vascular· Source

• Recruiting

  Prevail Global Study

  NCT06535854· Medtronic Vascular· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• High blood pressure2 recruiting
• Childhood cancers1 recruiting
• Coronary artery disease1 recruiting
• Lung cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  New Generation IGRA in Immunocompromised Individuals

  NCT02639936· Tuberculosis Network European Trialsgroup· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Pfizer· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Spinal muscular atrophy7 works · 0 trials
• High blood pressure6 works · 2 trials
• Primary biliary cholangitis4 works · 0 trials